Trellus Health Share Discussion Threads

[retirementfund] 24/5/2021 12:59

What are we all expecting as a scale back allocation only had 1000 specie shares

[martinikenny] 24/5/2021 09:52

With Interactive Investors ISA, I have a number of shares at 40p - not as 60p ( adobbing). I got 2.5 share for every £1 requested. This 'full' allocation is displayed at 0p. I guess it will get scaled back when the real numbers are in on Friday morning. (Quote from RNS - The expected admission date for Trellus Shares to commence trading on AIM is 8:00 a.m. on Friday, 28 May 2021. Shareholders will be informed their restricted allocation just before trading on Friday, 28 May 2021. )

[adobbing] 24/5/2021 08:55

Just checked my Interactive Investors ISA and it now shows 2500 Tellus health restricted offer.
Value shows as £0 and price shows as 0p
As I requested £1000 worth, I’m guessing that at 40p I got the full amount I subscribed for.

Updated after checking my account, I must have only gone for £1000 not £1500!

[welshborderer] 22/5/2021 12:14

Adding my thanks Wan (aka Speedy Gonzales)

[cambridgedon] 22/5/2021 09:43

Excellent. Thanks Wan.
Cd

[capitalist] 22/5/2021 07:16

Thanks wan

[wan] 22/5/2021 06:39

Initial Trellus Health thread, I will edit and populate the header further in due course.

[wan] 22/5/2021 06:34

LONDON, UK. AND NEW YORK, U.S. (20 May 2021). Trellus Health plc (AIM: TRLS), which is commercialising a scientifically validated, resilience-based, connected digital health solution for chronic condition management, is pleased to announce that it is today launching the Restricted Offer element of its Fundraising, having received very strong levels of support for the placing and subscription.

Key Fundraising Statistics:

Total Fundraising Size: £28.5 million

Issue Price per Trellus Share: 40 pence

Number of Ordinary Shares in issue at Admission 161,475,000

Market capitalisation at the Issue Price: circa £64.6 million

Trellus Health - Precision Medicine Meets Resilience-Driven Care
Because everyone living with a chronic condition should have hope and thrive.

Coordinating and Connecting Multidisciplinary Care for Complex Chronic Conditions, Starting with IBD

Trellus coordinates expert whole-person care rooted in resilience for people living with complex chronic conditions, improving outcomes and lowering overall healthcare costs and is transforming the way chronic conditions are treated.


The Company will utilise a team of licensed, multidisciplinary healthcare providers to deliver and coordinate care remotely via telehealth.

Technology platform and intellectual property:
The Company’s connected health solution will be enabled through an integrated suite of technology and IP to enable scalable remote access for the Company’s care team, patients, and their health care providers.

The primary components of the Company’s connected health solution include:
*TrellusElevateTM platform
*HIPAA-Compliant telehealth platform
*GRITTTM resilience assessment and personalised care plans
*Quad4XTM risk stratifier
*Digital education and behavioural tools
*Remote patient monitoring of symptoms, biomarkers, behaviours

The Company expects to generate initial revenue in 2021 through demonstration projects with healthcare payers in the New York City metropolitan area. The Company’s digitally-delivered solution and value-based recurring revenue model will present attractive unit economics, high margins, cash generation, and forward visibility as a function of the number of engaged patients in the program.

Informative interview/Q&A -
Trellus Health IPO - Management Q&A


Healthtech in the fast lane: What is fueling investor excitement?
As adoption of healthcare technology accelerates, it’s a good time for healthcare companies to consider investing in digital among nine potential “value pools.”